diagnostics News

March 28, 2011 – Trebing + Himstedt announced the launch of the award winning TH SCOPE diagnostic software to North America. The technology of the TH SCOPE enables users to replace multiple complex diagnostic tools with one, easy-to-use solution

Randox Laboratories is excited to announce the launch of its very own online blog – Lab Tests Blog

New low price virus removal service! No need to lug your PC down to a shop or wait for someone to arrive, service is all done through a secure internet connection! If your problem is not fixed then service is free!

A database of 29,000 unique biomarkers (for more than 1800 human diseases), which are manually extracted from US patent/WO (PCT) publications and PubMed abstracts.

Arrowhead Publishers and Conferences will be hosting the 3rd Annual Personalized Medicine Partnerships Conference in Washington, DC on April 11-12, 2011. This conference will shed light on issues of importance to the future of personalized medicine.

Future laboratories will utilize advanced diagnostic and information management technologies, and will require sophisticated and interoperable laboratory information systems.

Bharatbook added a new report on "US Diagnostic Market Outlook 2014" which gives the Huge investment in R & D and commercially successful innovations in US diagnostic industry.By RNCOS.

Bharatbook added a new report on "The 2011 US Molecular Diagnostics Market" which gives the emerging technologies in the molecular diagnostics market.

Even with achievements for some companies, numerous vaccines with apparently strong prospects have been hit by developmental delays and failures. Despite setbacks many developers are hopeful of a turnaround.

Diagnostic Marketing Association invites entries for outstanding creative advertising and communications campaigns

This conference will shed light on issues of importance to the future of personalized medicine, including the importance of Rx-Dx partnerships, adoption and the commercial realities of personalized medicine in the global healthcare marketplace.

Enzo Biochem, Inc. (NYSE:ENZ) reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

Enzo Biochem, Inc. (NYSE:ENZ) reported improved sequential results for the first fiscal quarter ended October 31, 2010

Enzo Biochem, Inc. (NYSE:ENZ) reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

Enzo Biochem, Inc. (NYSE:ENZ) reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.

New products will be made up of a mix and match of component parts from different platform companies, information technology providers and reagent companies.

Fast Market Research recommends "Diagnostics For All - Product Pipeline Analysis" from GlobalData, now available

Debra Harrsch, founder and chief branding officer of Brandwidth Solutions LLC, joined the board of directors of the Diagnostic Marketing Association (DxMA), the only organization catering to marketing professionals in the diagnostics industry.

Recently published research from GlobalData, "XCyton Diagnostics Ltd. - Product Pipeline Analysis", is now available at Fast Market Research

Fast Market Research recommends "NIPRO CORPORATION Market Share Analysis" from GlobalData, now available

Enzo Biochem (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.

Award Recognizes Cutting Edge Private Companies Driving the Future of Innovation

RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011 and will accept applications for restricted pilot grants of $5,000 to $20,000 worth of RayBiotech products and/or services beginning in early 2011.

New Medical Devices market report from GlobalData: "Xhale Diagnostics, Inc. - Product Pipeline Analysis"

The neurodegenerative space is a top-selling pharmaceutical market. Consider these facts: Sales among all drugs profiled in this report total $18.5 billion and are expected to increase 62% to $29.7 billion by 2012.

A sea of pink will stretch from Balboa Park to the 163 on Sunday, November 7 in an effort to raise public awareness and dollars for the fight against breast cancer.

Fast Market Research recommends "Biomerieux Sa Market Share Analysis" from GlobalData, now available

New Medical Devices market report from GlobalData: "Transasia Bio-Medicals Ltd. Market Share Analysis"

Growth is partly derived from an increased number of cardiovascular procedures and the need to run the activated coagulation time (ACT) test on individuals receiving heparin.

RayBiotech, Inc., a leading developer and supplier of multiplex protein and antibody arrays, was recently awarded an STTR research grant to identify protein markers that could potentially be used in a diagnostic test for endometriosis.

Bharatbook added a new report on "Cancer Profiling and Pathways: Technologies and Global Markets" gives a detailed overview and thorough analysis and insight of the present and future cancer profiling and pathways.

Cambridge Healthtech Institute, a premier information provider for the life sciences industry, will host its Eighth Annual Strategic Alliance Management Congress and the Inaugural Biopharma Licensing Congress on April 5-7, 2011 in Philadelphia, PA.

Company to take innovation to product with SBRI contract.

Our new report examines the commercial prospects for in vitro diagnostics (IVD) in the global healthcare market.

This FUN-raiser is ranked as one of the top three fundraisers for Susan G. Komen for the Cure®, San Diego

The ubiquity of infections makes their detection a healthcare priority and an ongoing opportunity for IVD companies. The aging of the population and emerging threats (MRSA, swine flu, etc) have impacted the market recently and will for years to come.

In 2008 and 2009, IVD companies small and large engaged in acquisitions to expand their product menu and pipeline or to create a larger footprint. Several acquisition events are of particular interest.

Bharatbook added a new report on "Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)" examines the commercial prospects for In Vitro Diagnostics (IVD) in the global healthcare market.

Alliance Bio-Medical Launches its Breakthrough Rapid HIV Urine Detection Test and the HIV Know Your Status Right Now (KYSRN) Workshop in Conjunction with the Lagos State AIDS Control Agency (LSACA) in Lagos, Nigeria.

The histology test segment is one of the fastest growing sectors in the IVD industry. The growing market has attracted many new entrants and competition has intensified. Histology/cytology will grow annually 5-10% over the next 5-10 years.

Years after launching the renowned 3-series analyzers, OROS has taken them to another level by adding user-inspired refinements with more input flexibility.

Given the unfortunate statistics of cancer in the developed world, innovation is a must. Growth rates in cancer testing tends to be higher than in other IVD fields. As cancer becomes more treatable, diagnostics are finding multiple expanded roles.

Hema diagnostic systems announces the availability of a new rapid diagnostic test for typhoid

Bharatbook added a new report on "South Africa In Vitro Diagnostics Market Outlook to 2016" provides key market data on the South Africa In Vitro Diagnostics (IVD) market.

San Diegans are loading up their golf clubs and heading to the course in an effort to raise money, spread awareness and help find a cure for breast cancer.

Genomic Expression, Inc. is featured at the Emerging Medical Technologies Spotlight Meeting today, where Gitte Pedersen, CEO delivered a 10-minute CEO presentation.

Aarkstore announce a new report "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads" through its vast collection of market research report.

Aarkstore announce a new report "The Worldwide Market for Cancer Diagnostics, 4th Edition" through its vast collection of market research report.

Bharatbook added a new report on "Diabetes Therapies & Diagnostics: Global Markets" which gives the market trends, strategies and profiles of leading diabetes companies.